SARAH WILLIAMS: Open Payments
NPI 1205210820 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 37 payments from 19 companies in 2025. Trend: 2023 $78 · 2024 $475 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $146 |
| ABBVIE INC. | 4 | $81 |
| Syndax Pharmaceuticals, Inc. | 3 | $75 |
| Janssen Biotech, Inc. | 4 | $71 |
| Legend Biotech USA Inc. | 3 | $59 |
| Astellas Pharma US Inc | 2 | $57 |
| ABIOMED | 2 | $50 |
| GENZYME CORPORATION | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Rigel Pharmaceuticals, Inc. | 1 | $25 |
Products named: CARVYKTI, JAKAFI, REVUFORJ, Cresemba, VENCLEXTA, SARCLISA, NIKTIMVO, EPKINLY.
Industry payments across KY — which companies pay providers there.
